Publications by authors named "Toru Setsu"

Claim this Profile
D
Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial.
Yoshitaka Arase, Tomomi Okubo, Taeang Arai, Masanori Abe, Tadashi Namisaki, Toru Setsu

Hepatol Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esophageal Varices as an Independent Predictor of Fatal Outcomes after Balloon-Occluded Retrograde Transvenous Obliteration in Patients with Hepatic Encephalopathy.
Shuichiro Iwasaki, Haruki Uojima, Shinya Sakita, Sakue Masuda, Kousuke Kubota, Toru Setsu

Dig Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model.
Shunta Yakubo, Hiroyuki Abe, Yawen Li, Marina Kudo, Atsushi Kimura, Toru Setsu

Diseases· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease.
Itsuo Nagayama, Kenya Kamimura, Takashi Owaki, Masayoshi Ko, Takuro Nagoya, Toru Setsu

Hepatol Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease.
Itsuo Nagayama, Kenya Kamimura, Takashi Owaki, Masayoshi Ko, Takuro Nagoya, Toru Setsu

Hepatol Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis.
Naruhiro Kimura, Kazuya Takahashi, Toru Setsu, Yusuke Horibata, Yusuke Kaneko

Hepatol Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver.
Masayoshi Ko, Kenya Kamimura, Takashi Owaki, Takuro Nagoya, Norihiro Sakai, Toru Setsu

Dis Model Mech· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of drug-induced liver-related adverse event trend reporting between 1997 and 2019.
Hiroteru Kamimura, Toru Setsu, Naruhiro Kimura, Makoto Miyazawa, Shota Kaneko

Hepatol Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning prediction model for treatment responders in patients with primary biliary cholangitis.
Naruhiro Kimura, Kazuya Takahashi, Toru Setsu, Shu Goto, Suguru Miida

JGH Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navitoclax improves acute-on-chronic liver failure by eliminating senescent cells in mice.
Yusuke Watanabe, Hiroyuki Abe, Naruhiro Kimura, Yoshihisa Arao, Natsuki Ishikawa, Toru Setsu

Hepatol Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinction of Drug-Induced Liver Injury From Autoimmune Hepatitis in Patients With Acute Liver Injury: Proposal of a Combination of Diagnostic Scores.
Keisuke Kakisaka, Nobuaki Nakayama, Kotaro Kumagai, Takuro Hisanaga, Takayuki Kondo, Toru Setsu

Gastro Hep Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression.
Norihiro Sakai, Kenya Kamimura, Hirotaka Miyamoto, Masayoshi Ko, Takuro Nagoya, Toru Setsu

J Gastroenterol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma.
Chiyumi Oda, Kenya Kamimura, Osamu Shibata, Shinichi Morita, Yuto Tanaka, Toru Setsu

Biochem Biophys Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.
Xue Shao, Haruki Uojima, Taeang Arai, Yuji Ogawa, Toru Setsu

Dig Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative risk of developing a new symptom in patients with primary biliary cholangitis and its impact on prognosis.
Naruhiro Kimura, Toru Setsu, Yoshihisa Arao, Norihiro Sakai, Yusuke Watanabe

JGH Open· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benign Duodenal Stenosis Caused by Huge Mesenteric Hematoma Conservatively Improved with Long-term Use of Double Elementary Diet Tube.
Toru Setsu, Takeshi Yokoo, Takeki Sato, Masaru Kumagai, Satoko Motegi

Intern Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A.
Takashi Owaki, Kenya Kamimura, Masayoshi Ko, Itsuo Nagayama, Takuro Nagoya, Toru Setsu

Dis Model Mech· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of duodenal variceal bleeding due to extrahepatic portal vein obstruction successfully treated with endoscopic injection sclerotherapy.
Ashu Hori, Yusuke Watanabe, Kazuya Takahashi, Takahumi Tonouchi, Naruhiro Kimura, Toru Setsu

Clin J Gastroenterol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of autologous fecal microbiota transplantation and elucidation of microbiota in diversion colitis.
Kentaro Tominaga, Atsunori Tsuchiya, Takeshi Mizusawa, Asami Matsumoto, Ayaka Minemura, Toru Setsu

DEN Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal increase in albumin-bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis.
Akira Sakamaki, Masaaki Takamura, Norihiro Sakai, Yusuke Watanabe, Yoshihisa Arao, Toru Setsu

PLoS One· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study.
Kosuke Matsumoto, Satoko Ohfuji, Masanori Abe, Atsumasa Komori, Atsushi Takahashi, Toru Setsu

J Gastroenterol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients.
Hiroteru Kamimura, Hirofumi Nonaka, Masaya Mori, Taichi Kobayashi, Toru Setsu

J Clin Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of 11 years with multidisciplinary therapy for hepatocellular carcinoma metastasis to the ovary and peritoneum: a case report.
Satoko Motegi, Takeshi Yokoo, Ryosuke Nozawa, Rie Azumi, Yuzo Kawata, Toru Setsu

Clin J Gastroenterol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan.
Akira Sakamaki, Kenya Kamimura, Takeshi Yokoo, Akihiko Osaki, Seiichi Yoshikawa, Toru Setsu

Medicine (Baltimore)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan.
Naruhiro Kimura, Masaaki Takamura, Nobutaka Takeda, Yusuke Watanabe, Yoshihisa Arao, Toru Setsu

Hepatol Int· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis